• Journal of Korean Neurosurgical Society
• /
• 제43권6호
• /
• pp.307-310
• /
• 2008

Limited therapeutic options are available for vancomycin intermediate-resistant Staphylococcus epidermidis (VISE) infections and no optimum therapy has been established. We report a case of VISE skull osteomyelitis that was successfully treated with linezolid. The patient was a 53-year-old man who presented with headache, nausea and dysphasia. Brain computerized tomography (CT) demonstrated a subdural hematoma in the left hemisphere. Craniotomy and hematoma evacuation was performed and he showed good recovery despite a scalp wound infection caused by methicillin-resistant Staphylococcus aureus (MRSA). The organism isolated from the scalp wound was sensitive to vancomycin. The patient was treated with intravenous vancomycin for 44 days. However, he showed a high fever, persistent positive methicillin-resistant Staphylococcus epidermidis (MRSE) blood cultures, and a deteriorating clinical status. He underwent infected skull bone flap removal and linezolid treatment for 35 days. During one year of follow up, he has not had any further episodes of osteomyelitis or fever. Linezolid has shown to be effective agent to eradiate osteomyelitis caused by VISE.

• 약학회지
• /
• 제50권2호
• /
• pp.78-83
• /
• 2006

VISA and VRE are the main causes of surgical infection, urinary tract infections and bacteremia in hospitals. In this study; we selected VISA (Vancomycin Intermediate resistant Staphylococcus aureus) and VRE (Vancomycin Resistant Enterococcus) isolated from the clinical isolates. One of the isolated strains indicated the high resistance to severel anti-biotics (Vancomycin, Teicoplanin, Mupirocin, Synercid, Ciprofloxacin, Gentamicin, Lincomycin, Cefotaxim, Meropenem). Antimicrobial activity of Bifidobacterium spp. against VISA and VRE were measured. About $10^4$ cells of VISA or VRE were mixed with 1,5 and 9 ml of Bifidobacterium and the final volume was adjusted to 10 ml with brain heart infusion (BHI) broth. The cell suspension was incubated for 3, 6, 9, and 24 hr, serially diluted and then plated on BHI agar plate. As numbers of Bifidobacterium were increased viable cell count of VISA and VRE decreased. The strongest antimicrobial activity of the Bifidobacterium was observed after 9hr incubation in any mixture, almost completely inhibiting the growth of VISA and VRE.

• Biotechnology and Bioprocess Engineering:BBE
• /
• 제5권3호
• /
• pp.153-158
• /
• 2000

Vancomycin belongs to the vancomycin-risocetin family of glycopeptides, and is a subclass of linear sugar containg peptides composed of seven amino acids. Its strochemical configuration forms the basic of a peptidoglycon monomer. The glycosylated hexapeptide chainconsists of chloro-$\beta$-hydroxytyrosines, p-hytidoglycines, N-anthylleucine and aspartic acid forms a rigid molecular frame work and gives the difficulty in the analysis. Voncomycin in the serum samples is usually estimated by liquid chromatography and the bacterial sensitivity was genereally tested by the microbiological assay. The pressent review deals with the qualitative, quantutative, microbioligical and immunological assays and the comparison of the quantitative methods. Clinical implications of vancomycin have also been cited in the review.

• 한국식품과학회지
• /
• 제26권3호
• /
• pp.295-299
• /
• 1994

Bacteroides는 대장의 상재균총 중 가장 많이 존재하는 균이다. 본 연구에서는 Bacteroides를 분리하여 동정하고 이들 균주들에 대하여 BL배지와 EG배지를 기본 배지로 하여 항생제 및 대사저해제에 대한 감수성 조사를 한 결과 vancomycin은 Bacteroides와 대장균 이외의 장내균들의 생육을 저해하는 것으로 나타났다. 성인에서 대장균은 Bacteroides에 비하여 숫적으로 훨씬 적게 존재하기 때문에 vancomycin이 첨가된 VA배지를 선택배지로 조제하여 한국인을 대상으로 기존의 NBGT 선택배지와 비교한 결과 선택성이 거의 동일한 것으로 나타났고 유아의 경우에는 VA배지가 NBGT보다 우수하였다.

• Childhood Kidney Diseases
• /
• 제12권2호
• /
• pp.245-249
• /
• 2008

복막염은 지속성 외래 복막투석 환자에게 있어 중요한 합병증 중 하나이다. 이러한 복막염은 잦은 재발과 최근 내성균의 출현으로 치료에 어려움을 겪고 있다. vancomycin 내성 장구균(VRE, Vancomycin-resistant Enterococcus)에 의한 복막염은 1999년에 국내에서 처음 보고된 이래로 계속 증가하고 있으나 아직까지 치료에 대해 명확한 기준이 없는 실정이다. 저자들은 복막투석 소아에서 리네졸리드(linezolid)로 VRE에 의한 복막염을 성공적으로 치료한 1례를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

• 한국미생물·생명공학회지
• /
• 제42권3호
• /
• pp.297-301
• /
• 2014

본 연구에서는 실리카겔을 이용한 반응액 부피당 표면적(surface area per volume of reaction solution)이 증가된 반코마이신 결정화 공정에서 이온성 액체의 영향을 조사하였다. 실리카겔로 표면적을 증가시킨 경우에 이온성 액체([BMIm][$BF_4$])를 접목하면 결정화 효율을 더욱 향상시킬 수 있었다. 실리카겔을 이용한 표면적이 증가된 결정화에서 이온성 액체(20%, v/v)를 첨가한 경우 결정화 4시간에 반코마이신 결정이 생성되었으며 실리카겔과 이온성 액체를 사용하지 않은 경우보다 결정화에 소요되는 시간을 6배 정도 단축시킬 수 있었다. 또한 이온성 액체 첨가량이 증가함에 따라 반코마이신 결정 입자크기가 감소할 뿐만 아니라 결정이 균일하고 일정해짐을 알 수 있었다.

• 한국임상약학회지
• /
• 제9권2호
• /
• pp.88-91
• /
• 1999

The purpose of this study was to compare the pkarmacokinetic parameters of vancomycin using a 2-compartment model in 8 Korean healthy volunteers and 8 lymphoma patients. Vancomycin (1.0 g) was administered by IV infusion over 60 minutes. The $\beta-phase$ rate constant $(\beta)$, apparent volume of distribution at steady srate $(V_{ss})$, total body clearance (CL) and area under the plasma level-time curve (AUC) of vancomycin in healthy volunteers were $0.15\pm0.02\;hr^{-1},\;33.8\pm4.12\;L/kg,\;5.36\pm0.61\;L/hr\;and\;185.8\pm20.5\;{\mu}g/ml{\cdot}hr$, respectively. The corresponding values in lymphoma patients ere $0.09\pm0.02\;hr^{-1},\;38.2\pm5.11\;L/kg,\;4.58\pm0.52\;L/hr\;and\;218.3\pm22.9\;{\mu}g/ml{\cdot}hr$. There were significant differences (p<0.05) in ${\beta}$ and CL between healthy volunteers and lymphoma patients.

• 대한의생명과학회지
• /
• 제18권1호
• /
• pp.83-85
• /
• 2012

Vancomycin-resistant (VR)-E. faecium and VR-E. faecalis were isolated simultaneously from a rectal swab of a patient diagnosed with pneumonia in an intensive care unit (ICU). The patient was treated with various antibiotics including vancomycin. Only VR-E. faecium was continually isolated from the rectal swab at one and two weeks of the treatment. Identical vanA, IS1216V, and IS1542 genes were detected in both VR-E. faecium and VR-E. faecalis isolates which showed equal resistance against vancomycin and teicoplanin, but IS1251 was not detected. VR-E. faecium showed stronger multi-drug resistance than VE-E. faecalis. This result supports the reason why VR-E. faecium is one of the major pathogens in nosocomial infections.

• Journal of Microbiology and Biotechnology
• /
• 제24권3호
• /
• pp.427-430
• /
• 2014

We developed a novel immunochromatographic assay (ICA) (EZ-Step VanA rapid kit; Dinona, Korea) for the detection of VanA ligase from vancomycin-resistant enterococci (VRE). Of eight monoclonal antibodies screened by ELISAs, the VanA ligase ICA constructed with 1H9 plus 3G11 showed the greatest reactivity. The detection limit of the kit was $6.3{\times}10^6$ CFU per test. Of 127 vancomycin-resistant microorganisms, 100 vanA VRE were positive in the VanA ligase ICA, and 27 non-vanA vancomycin-resistant isolates were negative. These results were consistent with those of the PCR analyses. Thus, our ICA is a reliable and easy-to-use immunological assay for detecting VanA-producing VRE in clinical laboratories.

• Journal of Microbiology and Biotechnology
• /
• 제31권2호
• /
• pp.189-196
• /
• 2021

Periplanetasin-2 from cockroach exhibits broad-spectrum antimicrobial activity. The underlying antibacterial mechanisms rely on the stimulation of reactive oxygen species overproduction to induce apoptotic cell death. A promising strategy to increase the bioavailability of periplanetasin-2 involves reducing the dose through combination therapy with other antibacterials that show synergistic effects. Thus, the synergistic antibacterial activity of periplanetasin-2 with conventional antibacterial agents and its mechanisms was examined against Escherichia coli in this study. Among the agents tested, the combinations of periplanetasin-2 with vancomycin and chloramphenicol exhibited synergistic effects. Periplanetasin-2 in combination with vancomycin and chloramphenicol demonstrated antibacterial activity through the intracellular oxidative stress response. The combination with vancomycin resulted in the enhancement of bacterial apoptosis-like death, whereas the combination with chloramphenicol enhanced oxidative stress damage. These synergistic interactions of periplanetasin-2 can help broaden the spectrum of conventional antibiotics. The combination of antimicrobial peptides and conventional antibiotics is proposed as a novel perspective on treatments to combat severe bacterial infection.